Apr 27
|
Will Eli Lilly's Rally Continue? Here's How to Trade the Stock
|
Apr 27
|
US STOCKS-Wall St rallies as Meta earnings offset economy worries
|
Apr 27
|
Why Eli Lilly Stock Is Rising Today
|
Apr 27
|
Why Eli Lilly Shares Are Trading Higher Today
|
Apr 27
|
Eli Lilly Results Disappoint. Hopes for Obesity Drug Are Lifting the Stock.
|
Apr 27
|
Eli Lilly Unveils New Obesity Data As Mounjaro Blows Past Sales Estimates
|
Apr 27
|
Eli Lilly to seek obesity drug approval that could disrupt weight loss market
|
Apr 27
|
US STOCKS-Wall St gains as upbeat earnings offset economy worries
|
Apr 27
|
Drugmakers brace for serious headwinds ahead
|
Apr 27
|
Lilly (LLY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
|
Apr 27
|
Drugmakers scout for deals, ramp up research spending
|
Apr 27
|
Is Eli Lilly Stock a Strong Buy After Q1 Earnings?
|
Apr 27
|
US STOCKS-Wall St set to open higher as earnings offset economy worries
|
Apr 27
|
Dow Jones Futures Rise: Meta Soars, Drug Giants Climb, Specialty Chip Plays Dive
|
Apr 27
|
Eli Lilly (LLY) Q1 Earnings Lag Estimates
|
Apr 27
|
Eli Lilly raises annual profit forecast on strength of diabetes drug
|
Apr 27
|
Lilly Reports First-Quarter 2023 Financial Results, Highlights Continued Core Business Growth and Pipeline Momentum
|
Apr 27
|
Powerful new obesity drug poised to upend weight loss care
|